Programme

Programme at a Glance

PRE-CONGRESS WORKSHOPS
25 July 2021
Time Pre-Congress Workshop 1
Kidney transplant immunopathology
Pre-Congress Workshop 2
Organ donation & procurement
Pre-Congress Workshop 3
Workup of potential transplant recipients
 
0815-0830 Course overview

Vathsala Anantharaman
Course overview

Omar Sulaiman
Course overview

Rosnawati Yahya
 
0830-0900 0830 – 0915
The immune response to transplantation

Minnie Sarwal
Active donor detection in Spain. Is there a wrong or a right way to do it?

Chloe Balleste
CKD burden in Asia

Vivekanand Jha
 
0900-0930 0915 – 0930
BREAK
Ancillary testing in brain death

Gene Sung
Economics of transplantation in Asia

Sunita Bavanandan
 
0930-1000 0930 – 1015
Immune cells involved in transplantation rejection

Lim Wai Hon
Updates on donor maintenance to deliver quality organs for transplantation

Omar Sulaiman
Optimising potential recipients for kidney transplantation

Vathsala Anantharaman
 
1000-1030 COFFEE BREAK
1030-1100 1030 – 1115
Tissue typing and detection of pre-formed antibodies

Melissa Yeung
Understanding refusals: what makes family consent?

Omid Ghobadi
Evaluation of kidney transplant recipients – an overview

TBC
 
1100-1130 1115 – 1145
Induction therapy

Daniel Brennan
Challenges in family donor conversation

Sumana Navin
and 
Sujatha Suriyamoorthi
Surgical aspects of kidney transplant recipients

Murali Sundram
 
1130-1200 1145 – 1200
BREAK
Consensus guideline on immunological evaluation of transplant recipients

Jeremy Chapman
 
1200-1230 Desensitisation – HLA antibodies, ABOi transplantation

Lim Soo Kun
Bringing teams together, sharing experience

Omar Sulaiman
Managing the original kidney disease

Steve Alexander
 
1230-1300 Immunosuppressive drugs

Romina Danguilan
Normothermic machine perfusion for liver allograft

Peter Friend
Pre-transplant cardiac evaluation

Marcelo Cantarovich
 
1300 -1400 LUNCH
1400-1430 Renal allograft histopathology: Banff Classification

Mark Haas
HCV and HIV positive donors

Dorry Segev
Evaluation of liver transplant recipients

TBC
Vitallink Session I
1430-1500 T cell mediated rejection: diagnosis and management

Kate Wyburn
Biological markers in organ donation and transplantation: an update

TBC
Surgical aspects of liver transplant recipients

Mohamed Rela
 
1500-1530 1500 – 1515
BREAK
The power of social media and how it can affect organ donation

Rafidah Abdullah
Pediatric renal recipient work-up

Yap Hui Kim
 
1530-1600 1515 – 1545
Antibody mediated rejection: diagnosis and management

Brian Nankivell
Organ donation and COVID 19: Clinical issues
Marian Irazabal
What does the HLA crossmatch mean?

Melissa Yeung
 
Organ donation and COVID 19: World registries

Maria Paula Gomez
1600-1630 1545 – 1630
Strategies for achieving tolerance

Megan Sykes
i-DTI and telemedicine
Estephan Arredondo Cordova
Frailty-assessment and prognosis

Dorry Segev
 
Artificial intelligence and robotics in organ donation

Marian Irazabal
1700-1830 OPENING CEREMONY

 

Congress (Day 1)
26 July 2021
Time PLENARIES
0830-0900 Plenary 1: Management of transplantation in the digital era

Dorry Segev
0900-0930 Plenary 2: Updates on Tregs and tolerance

TBC
0930-1000 Plenary 3: The challenges of prolonging kidney allograft survival

Jeremy Chapman 
1000-1030 COFFEE BREAK
1030-1230 STATE OF THE ART SYMPOSIUM (1)
  Kidney transplant Liver transplant Heart & Lung Donation & ethics
1030-1050 Deceased donor kidney quality and allograft outcome

Yang Jaeseok
Epidemiology of non-alcoholic fatty liver and non-alcoholic steatohepatitis: implications for liver transplantation

Dan Yock Yong
Setting up a pediatric heart transplant and MCS (mechanical circulatory support) programme

David Morales
The Declaration of Istanbul on Organ Trafficking and Transplant Tourism 2018

Mustafa al-Mousawi
1050-1110 Long-term living donor outcome: cause for concern?

TBC
Role of bridging therapies in acute and acute-on-chronic liver failures

Shiv Kumar Sarin
mTOR Inhibitors in heart transplantation

Azmee Ghazi 
Importance of post donation care: a comparison of practices around the world

Tina Coco
1110-1130 Causes of death with function – what can we do to prevent it?

Steve Chadban
Emerging indications for liver transplantation

James Fung
Pulmonary hypertension and lung transplantation

Allan Granville
Malaysia: curbing illegal overseas transplantation. Should we deny recipients of free immunosuppressants?

Ghazali Ahmad
1130-1150 Managing a second transplant

TBC
Living donor liver transplantation for acute on chronic liver failure

Subhash Gupta
Bridging to lung transplantation: who, when and with what?

Hiroshi Date
DCD – Euthanasia, withdrawal of therapy, reintubation…where do we draw the line?

Chloe Balleste
1150-1210 Trials in kidney transplantation

Jonathan Craig
Selection criteria for transplantation in HCC

Kyung Suk Suh 
Future technology in cardiac xenotransplantation 

TBC
Opting in vs opting out: which works better?

Marti Manyalich
1210-1230        
1230-1400 INDUSTRY SPONSORED LUNCH SYMPOSIUM
  ABSTRACT PRESENTATIONS
(selected oral presentations)
1400 -1410        
1410 - 1420        
1420 - 1430        
1430 - 1440        
1440 -1450        
1450 -1500        
1500 -1510        
1510 -1520        
1520 - 1530        
1530 -1540        
1540-1610 COFFEE BREAK
1610-1640 Plenary 4: Chimerism, transplant tolerance and beyond 

Megan Sykes
1640-1800 DEBATES and STATE OF THE ART SYMPOSIUM (2)
  Kidney - debates Liver - debates Heart & Lung Transplantation and COVID 19
1640-1720 Living donors should be incentivised

TBC
Active drinkers should be transplanted

Pro: James Fung
Con: Mohamed Rela 
Artificial intelligence in LVAD implantation

David Morales (20 mins)
COVID 19: Results of the international survey

Marcelo Cantarovich (20 mins)
Less invasive VAD Implantation

TBC (20 mins)
1720-1800 Robotic renal transplantation vs Open renal transplantation – which is a better technique?

Robotic: Pranjal Modi
Open: Sandeep Guleria
Liver transplantation for liver metastasis

Pro: Deniz Balci
Con: Alfred Kow
Late complications following lung transplantation

Allan Glanville (20 mins)
Clinical presentation, complications, and outcomes in solid organ transplant recipients

Madeleine Heldman (25 mins)
Living related lung transplant – Japanese model

Hiroshi Date (20 mins)
Management of the transplant programme in the time of COVID-19

Hiroto Egawa (25 mins)

 

Congress (Day 2)
27 July 2021
Time PLENARIES AND REGISTRIES
0800-0830 Plenary 5: Liver transplantation in metastatic liver disease

Deniz Balci
0830-0900 Plenary 6: 50 donors p.m.p. is not a dream anymore: how did Spain do it?

Marti Manyalich 
0900-1000 Asian transplantation registries for collaboration and harmony
0900-0915: What can we learn from registries? 
Jeong Jong Cheol
0915-0930: Setting up an Asian registry for COVID-19 
Terence Kee
0930-0945: Setting up an Asian registry for transplantation tourism 
Toby Coates
0945-1000: Improving harmony among registries 
Kenji Yuzawa
1000-1030 COFFEE BREAK
1030-1230 STATE OF THE ART SYMPOSIUM (3)
  Kidney transplant Liver transplant Donor and procurement  Surgical aspects of kidney transplantation
1030-1050 T cell mediated rejection

Sundaram Hariharan
Current trends of immunosuppression in liver transplantation

James Fung
Organ donation innovative strategy in South East Asia (ODISSeA). what have we learnt?

Muhammad Iqbal Abdul Hafiz
The complex living donor

Mustafa al-Mousawi
1050-1110 Highly sensitised recipient: desensitisation strategies-: practical approaches

TBC
Acute liver failure and transplantation – indicators for poor outcome

Subhash Gupta
Deceased donation. should we allow donor family to meet recipients?

Tina Coco
The complex recipient

Clarence Lei
1110-1130 Management of ABMR: Current updates

Kate Wyburn
ABO incompatible liver transplantation

Albert Chan
Overcoming cultural barriers. is this the key to gaining consent?

Katy Najafizadeh
Role of interventional radiologist in kidney transplantation

Basri Johan
1130-1150 Paired kidney exchange: success and challenges and lesson learnt

Vivek Kute
Hepatitis B reactivation post liver transplantation

TBC
Increasing demand on master education for donation & transplantation.

Marti Manyalich
Coping with donor complications

Sandeep Guleria
1150-1210 ABO incompatible renal transplantation

Kazunari Tanabe
Role of Interventional radiology post liver transplant

Basri Johan 
Burnout amongst donor coordinators: is it real?

Sumana Navin
When should I not proceed with kidney transplantation from a surgical perspective?

Anant Kumar
1210-1230        
1230-1400 INDUSTRY SPONSORED LUNCH SYMPOSIUM
1400-1600 STATE OF THE ART SYMPOSIUM (4)
  Transplant immunology Surgical aspects of liver transplantation Transplant infectious disease Biomarkers in transplantation
1400-1420 What is immunological risk?

TBC
Advances in surgical techniques in living donor liver transplantation

Deniz Balci
Asymptomatic bacteriuria post kidney transplantation: what to do

Angela Webster
Biomarkers in acute rejection

Manikkam Suthanthiran
1420–1440 High resolution HLA typing in solid organ transplantation: is it necessary?

Melissa Yeung
Laparoscopic living donor hepatectomy: safety and efficacy

Alfred Kow
Unusual infections from deceased donors

Mustafa al-Mousawi
Biomarkers in chronic allograft dysfunction

Minnie Sarwal
1440-1500 HLA mismatching and kidney transplant outcomes: what matters?

Lim Wai Hon

Long term liver transplant outcomes

Albert Chan

Difficult fungal infections: diagnostic approaches and management

Vivek Kute
Role of biomarkers in personalised Immunosuppression: are we there yet?

TBC
1500–1520 Denovo DSA: Risk factors and clinical consequences

Kate Wyburn 
Organ preservation

Glenn Bonney
Latent TB: detection and management

Vivekanand Jha
Gut microbiome in solid organ transplantation

Steve Chadban
1520–1540 Clinical relevance of non-HLA antibodies

Minnie Sarwal
Pediatric liver transplantation

Mohamed Rela
Respiratory viral infections in transplant recipients

Atul Humar
Cell-free DNA and active rejection in kidney allografts

TBC
1540-1550        
1550-1620 COFFEE BREAK
1620–1800 STATE OF THE ART SYMPOSIUM (5)
  Kidney Women in transplantation Transplant immunology Post-transplant complications
1620-1640 Belatacept in kidney transplant: past and future perspectives

Lionel Rostaing
Equity in donors and recipients in places with disparities

Vathsala Anantharaman
Eplet matching in kidney transplantation

Lim Wai Hon
Transplant-associated thrombotic microangiopathy - more than just clot and bleed

Masaomi Nangaku
1640-1700 Optimising mycophenolic acid exposure in kidney transplant recipients: time for target concentration intervention

Wong Hin Seng
Equity in leadership

Germaine Wong
Role of DSA monitoring post kidney transplantation

Christophe Legendre
Post- transplant lymphoproliferative disorders

Atul Humar
1700-1720 Can mTORi be combined with CNI in renal transplantation? Experimental and clinical evidence

Yang Chul Woo
Fertility and pregnancy post solid organ transplantation

Maggie Ma
The influence of immunosuppressive agents on the risk of denovo DSA in solid organ transplant recipients

Lionel Rostaing 
Risk of cancer after solid organ transplant in childhood

Jonathan Craig
1720-1740 Evolution of Banff Classification: 20 years ahead

Brian Nankivell
Sensitisation during pregnancy: what is the impact?

TBC
Targeting complement as rejection therapy

TBC
Obesity and metabolic syndrome post transplantation: prevention and management

Kim Yeong Hoon
1740-1800
MicroRNA profiles predictive of organ allograft status

Manikkam Suthanthiran
How women can bring change to organ transplantation - the Mongolian experience

Lkhaakhuu Od-Erdene
The role for inhibition of the CD40-CD154 pathway in co-stimulation blockade

Lionel Rostaing
Medication adherence

TBC
1800-1810        

 

Congress (Day 3)
28 July 2021
Time PLENARIES
0800-0830 Plenary 7: The role of B cells in transplantation

TBC
0830-0900 Plenary 8: Experimental xenotransplantation

Megan Sykes
0900-1000 STATE OF THE ART SYMPOSIUM (6) 
  Innovation in transplantation Post-transplant complications Asian experts in Transplantation Women in transplantation
0900-0920 Artificial kidneys

TBC
Cardiovascular disease in transplantation

TBC
Translational research in transplantation

Hideki Ohdan
 
0920-0940 Clinical transplantation: how do we measure performance?

Steve Chadban
Current strategies in post-transplant diabetes mellitus

Masaomi Nangaku
CD47 in xenotransplantation

Yong-Guang Yang 
 
0940-1000 Future of research in transplantation

Jeremy Chapman
Bone disease post transplantation: spectrum, impact, prevention and management"

Wong Jiunn
Role of macrophages in transplant oncology and immunology

Nancy Kwan Man
 
1000-1030 COFFEE BREAK
1030- 1230 ABSTRACT PRESENTATIONS
(selected oral presentations)
Vitallink Session II
How to improve self-sufficiency in Asia? The experience in various countries
Women in transplantation
1030-1040      Vietnam (15 mins)  
1040- 1050      
1050-1100      Myanmar

Khin Maung Htay (15 mins) 
 
1100-1110     Bangladesh

Harun Ur Rashid (15 mins)
 
1110-1120     Indonesia

Atma Gunawan (15 mins) 
 
1120-1130     Sri Lanka 

Ruwan Dissanayake (15 mins)
 
1130-1140      
1140-1150     Nepal

Dibya Singh (15 mins)
 
1150-1200      
1200-1210      Panel discussion: How to achieve self-sufficiency in Asia? 

Marcelo Cantarovich
 
1210-1220    
Ejaz Ahmed (10mins)
 
1220-1230    
Pandaan Batchuluun (10 mins)
 
1230-1400 INDUSTRY SPONSORED LUNCH SYMPOSIUM
1400-1510 STATE OF THE ART SYMPOSIUM (7) and ROUNDTABLES
  Transplantation in Asia – challenges & way forward Transplant infectious diseases ASTREG Workshop
Small group meeting for registry (for
transplantation tourism)
The ODISSeA project
(Malaysia,
Thailand, Myanmar, Philippines)

Maria Gomez
Koong Jun Kit
Muhammad Iqbal
Chatchai Mingmalairak
Htar Kyi Swe
Khin Thida Thwin
Maria Bad-Ang
Stephanie Andres
1400-1420 Role of Vitallink in advancing transplantation in Asia

Curie Ahn
CMV: Consensus on monitoring, prevention, and therapeutic updates

Atul Humar
1420-1440 Longest on waiting list vs fittest and shortest waiting time gets the kidney

Rosnawati Yahya
Torque teno virus (TTV) in transplantation

TBC
1440-1500 The Spanish model: can it be implemented in Asia?

Chloe Balleste
Hepatitis C: When is the optimal time to treat?

Tan Soek Siam
1500-1510    
1515-1600 CLOSING CEREMONY & AWARDS CEREMONY

 

(Updates as 26 January 2021)